针对糖尿病和肺癌之间的分子交叉来进行治疗干预
Alireza Azani1,2, Nahal Aghajamal Avval3, Mohammad Saeed Soleimani Meigoli4
1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
2型糖尿病 (T2DM) 增加了20-48%的肺癌风险. 甲胺在改善糖尿病肺癌患者的治疗结果方面表现有前途,突出显示了血糖控制在癌症治疗中的重要性.
科学领域:
- 内分泌学和瘤学 在内分泌学和瘤学.
- 代谢综合征和癌症生物学
背景情况:
- 2型糖尿病 (T2DM) 是一个日益严重的全球健康问题.
- 新出现的证据表明T2DM与癌症,特别是肺癌之间存在复杂的相互作用.
研究的目的:
- 调查T2DM与肺癌之间的关联,包括共享的风险因素和分子机制.
- 量化T2DM对肺癌发病率,进展和治疗反应的影响.
- 评估血糖控制和抗糖尿病治疗在肺癌中的作用.
主要方法:
- 对来自PubMed,Scopus和Web of Science的研究进行了叙事审查.
- 搜索术语集中在T2DM,肺癌,高血糖症,胰岛素抵抗和相关概念上.
- 纳入标准优先考虑的人类研究,探讨T2DM在肺癌中的流行病学,机制学和治疗方面.
主要成果:
- 患有T2DM的人患肺癌的相对风险增加了20-48%.
- 共同的风险因素包括肥胖,吸烟和不活动;K-Ras和PI3K/Akt等分子通路都与此有关.
- 甲胺使用与减少肺癌发病率和改善无进展生存率相关.
结论:
- T2DM显著影响肺癌的发展和预后.
- 整合血糖控制,特别是与甲胺和EGFR-TKI组合,是一个有前途的治疗策略.
- 未来的研究应该探索基于生物标志物的分层,以对糖尿病肺癌患者进行个性化治疗.
更多相关视频
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Diabetes Mellitus: Type 2 and Gestational
